CLIVATUZUMAB
UNII RGU8A332UL

Substance Identification & Data

This profile provides standardized clinical and technical data for Clivatuzumab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) RGU8A332UL.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1622075-09-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
RGU8A332UL
CAS Registry Number
1622075-09-5
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
CLIVATUZUMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C88638
National Cancer Institute reference terminology for clinical and research data.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Clivatuzumab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

CLIVATUZUMAB

Common Names & Synonyms

CLIVATUZUMAB [USAN]
IMMUNOGLOBULIN G1, ANTI-(HUMAN MUCIN MUC1) (HUMAN-MOUSE MONOCLONAL HPAM4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL HPAM4 .KAPPA.-CHAIN, DIMER
IMMUNOGLOBULIN G1, ANTI-(HUMAN MUCIN MUC1) (HUMAN-MOUSE MONOCLONAL HPAM4 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL HPAM4 .KAPPA.-CHAIN, DIMER

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus